Welcome to our blog post on Darier's Disease! As a medical professional, you understand the importance of staying up-to-date on rare skin conditions. That's why we're here to provide you with essential information about this unique disease. From its symptoms and treatment options to management techniques, we've got you covered. Keep reading to discover all there is to know about Darier's Disease and how it affects those who suffer from it.
Darier's Disease is a rare genetic skin condition that affects approximately one in every 30,000 individuals. It was first discovered by French dermatologist Ferdinand-Jean Darier in 1889 and is also known as keratosis follicularis.
The disease is caused by mutations in the ATP2A2 gene, which plays a role in regulating calcium levels within skin cells. As a result of these mutations, there is an abnormal buildup of protein within the cells, leading to inflammation and lesions on the skin.
Symptoms may include small bumps or papules on the chest, back, scalp or face; thickened nails with ridges and grooves; and redness and scaling around the nose and mouth. Additionally, those with severe forms of Darier's Disease may experience blistering or crusting of their skin.
Darier's Disease is a rare genetic skin disorder that affects the sebaceous glands, which are responsible for producing oil in our skin. The symptoms of Darier's Disease generally appear during adolescence or early adulthood and affect both sexes equally.
The most common symptom of this condition is the development of small, firm bumps on the face, scalp, chest and back. These bumps can be red or brown in color and can become crusty or scaly over time.
Other less common symptoms include a foul odor from affected areas due to bacterial infections, sensitivity to sunlight leading to easy sunburns along with psychological issues like depression due to its unsightly appearance.
Darier's Disease is a rare genetic skin disorder that affects many people around the world. It can cause various symptoms such as skin lesions, nail abnormalities, and sometimes even mental health issues.
1.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
2.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
3.
Recurrent UTIs impact eGFR in children with vesicoureteral reflux
4.
Month-Long Wait Times Caused by US Physician Shortage.
5.
Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.
1.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
2.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
3.
Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice
4.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
5.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation